In a single day, the Alzheimer’s science community lost two pioneering researchers, Allen Roses, MD, who led the team that in 1992 identified Apolipoprotein ε4 as a major risk gene for Alzheimer’s disease (AD), and Dale Schenk, PhD, whose seminal work in immunotherapy led to the first clinical trial of a beta-amyloid vaccine for AD. Both men died Friday, September 30, 2016.
from Dementia Big http://ift.tt/2h2J8Gq via alcoholic dementia
http://ift.tt/2gTCHYC
No comments:
Post a Comment